Germany Pharmaceutical Cold Chain Logistics Market Size (2024 - 2029)

The Germany Pharmaceutical Cold Chain Logistics Market is experiencing growth, driven by increased demand for temperature-controlled transportation of pharmaceutical products, particularly following the COVID-19 pandemic. The market's expansion is supported by regulatory changes in the European Union, which have broadened the requirements for temperature control in pharmaceutical distribution. This has led to the development of specialized warehouses equipped with advanced cold chain systems to ensure optimal storage and transportation conditions for temperature-sensitive products.

Market Size of Germany Pharmaceutical Cold Chain Logistics Industry

Germany Pharmaceutical Cold Chain Logistics Market Summary
Study Period 2020 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2020 - 2022
CAGR > 5.00 %
Market Concentration Medium

Major Players

Germany Pharmaceutical Cold Chain Logistics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Germany Pharmaceutical Cold Chain Logistics Market Analysis

  • The Germany Pharmaceutical Cold Chain Logistics Market is valued at USD 2150 Million and is expected to register a CAGR of 5% during the forecast period. The Germany Pharmaceutical cold-chain logistics market benefited from the COVID-19 outbreak. The Federal Association of E-Commerce and Mail Order Business estimates that during the epidemic, internet demand for pharmaceuticals grew by 88 per cent, and purchases from drugstores (By over 30 per cent). However, due to the poor prognosis for demand and supply caused by COVID-19 limits for end users, the German cold chain logistics market experienced a fall in revenue and growth in 2020.
  • One of the most significant biotech hubs in the world is Germany. During the COVID-19 pandemic, the turnover of specialized biotechnology businesses surpassed USD 4.8 Billion, which was a record high since 2005.
  • Approximately 80% of pharmaceutical items in the European Union currently need to be transported under temperature control. Pharmaceutical laws in the majority of nations for years merely required that products be stored according to the manufacturer's specifications.
  • However, the EU has published guidelines on safe distribution procedures for pharmaceuticals intended for human use, extending the need for transportation-related temperature control and broadening coverage to embrace over-the-counter medications. In order to meet these demands, a number of warehouses with cold chain systems are created to guarantee the best conditions for the storage and transportation of temperature-sensitive goods.
  • For instance, the first cryopreservation warehouse will be constructed at the Mutterstadt site in Germany by Frigo-Trans (a German pharmaceutical logistics service) in November 2022. In the qualified storage area of this warehouse, 24 liquid nitrogen-operated low-temperature storage tanks from industry leader and supplier Cryotherm GmbH & Co. KG are available. These tanks are ideal for storing delicate biological and medical products, such as vaccines or biological samples.

Germany Pharmaceutical Cold Chain Logistics Industry Segmentation

The Transportation and planning of a pharmaceutical supply chain that is maintained within a range of particular, low temperatures are referred to as pharmaceutical cold chain logistics.

Germany's Pharmaceutical Cold Chain Logistics Market is segmented By Service (Storage, Transportation(Road, Rail, Air, Sea), and Value-added Services), By Temperature Type (Chilled, Frozen, and Ambient), By Product (Generic Drugs and Branded Drugs), By Application (Bio Pharma, Chemical Pharma, and Specialized Pharma). The report offers Germany's Pharmaceutical Cold Chain Logistics Market size and forecasts in value (USD Billion) for all the above segments.

By Service
Storage
Transportation
Road
Rail
Air
Sea
Value-added Services
By Temperature Type
Chilled
Frozen
Ambient
By Product
Generic Drugs
Branded Drugs
By Application
Biopharma
Chemical Pharma
Specialized Pharma
Need A Different Region Or Segment?
Customize Now

Germany Pharmaceutical Cold Chain Logistics Market Size Summary

The Germany Pharmaceutical Cold Chain Logistics Market is experiencing growth driven by the increasing demand for temperature-sensitive pharmaceuticals, particularly in the wake of the COVID-19 pandemic. The pandemic highlighted the critical need for robust cold chain logistics, as a significant portion of pharmaceutical products in the European Union require temperature-controlled transportation. This has led to the establishment of advanced cold chain facilities, such as the cryopreservation warehouse by Frigo-Trans, to ensure optimal storage and transportation conditions for sensitive medical products. The rise of online pharmacies, fueled by enhanced internet access and healthcare reforms like electronic prescriptions, has further amplified the demand for cold chain logistics in Germany. The apo.com Group, a rapidly growing online pharmacy, exemplifies this trend, with its market share increasing significantly as more consumers turn to online platforms for their pharmaceutical needs.

Germany's position as a leading biotech hub in Europe is bolstered by its substantial production of biopharmaceuticals, with a significant concentration of active biopharmaceutical ingredients manufactured in the southern regions. Despite its strong presence, Germany faces competition from countries with more favorable tax structures for biopharmaceutical production. The country's pharmaceutical logistics market is characterized by a fragmented landscape with a few specialized players, such as DHL and Trans-o-flex, offering advanced logistics solutions. Recent expansions, like DHL's new life sciences and healthcare campus, underscore the growing importance of temperature-controlled logistics facilities. Additionally, companies like Logistics 4Pharma are enhancing their service offerings to meet the complex needs of the pharmaceutical industry, including ultra-deep-freeze warehousing for highly sensitive medicines. This evolving market landscape reflects Germany's commitment to maintaining its leadership in the pharmaceutical sector through innovation and strategic investments in cold chain logistics.

Explore More

Germany Pharmaceutical Cold Chain Logistics Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Current Economic Scenario

    2. 1.2 Technological Trends and Automation in Cold Storage Facilities

    3. 1.3 Government Regulations and Initiatives

    4. 1.4 Value Chain / Supply Chain Analysis

    5. 1.5 Impact of Emission Standards and Regulations in the Cold Chain Industry

    6. 1.6 Insights into Refrigerants and Packaging Materials used in Refrigerated Warehouses

    7. 1.7 Spotlight on Major Pharmaceutical Hubs/Regions

    8. 1.8 Impact of COVID-19 on the Market

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Service

      1. 2.1.1 Storage

      2. 2.1.2 Transportation

        1. 2.1.2.1 Road

        2. 2.1.2.2 Rail

        3. 2.1.2.3 Air

        4. 2.1.2.4 Sea

      3. 2.1.3 Value-added Services

    2. 2.2 By Temperature Type

      1. 2.2.1 Chilled

      2. 2.2.2 Frozen

      3. 2.2.3 Ambient

    3. 2.3 By Product

      1. 2.3.1 Generic Drugs

      2. 2.3.2 Branded Drugs

    4. 2.4 By Application

      1. 2.4.1 Biopharma

      2. 2.4.2 Chemical Pharma

      3. 2.4.3 Specialized Pharma

Germany Pharmaceutical Cold Chain Logistics Market Size FAQs

The Germany Pharmaceutical Cold Chain Logistics Market is projected to register a CAGR of greater than 5% during the forecast period (2024-2029)

Trans-o-flex (ThermoMed), DHL, Biotech and Pharma Logistics, GDP Network Solutions GmbH and Transmed Transport GmbH are the major companies operating in the Germany Pharmaceutical Cold Chain Logistics Market.

Germany Pharmaceutical Cold Chain Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)